Caltrate

Caltrate is a branded line of calcium supplements sold in multiple formulations for dietary calcium intake and bone-health support. The brand is associated primarily with calcium carbonate products rather than calcium citrate. Its formulations have been marketed in tablet and other dosage formats, with some products combining calcium with vitamin D and additional micronutrients. The brand's ownership history reflects changes in the consumer-health industry. Caltrate was originally associated with Pfizer and its predecessor Wyeth, and the brand has also been linked to GlaxoSmithKline in different commercial arrangements. In Japan, Caltrate has been associated with Hisamitsu Pharmaceutical. Following the separation and formation of Haleon as a consumer-health company, Caltrate is identified as a Haleon brand. Exact ownership and distribution arrangements can vary by country and product registration. A commonly cited Caltrate formulation provides 600 milligrams of calcium carbonate per serving. This distinguishes the product from the smaller amount of calcium often present in a general multivitamin. Caltrate Plus is described as combining calcium carbonate with vitamin D3, vitamin K1, magnesium, zinc, copper, and manganese. Product composition, serving size, dosage form, and availability may differ across markets, so individual packaging and local regulatory labeling are authoritative. Caltrate's positioning centers on convenient calcium supplementation and support for bone-health routines. In the United States and other markets, the brand has been sold through consumer-health and retail channels. It has also achieved substantial recognition in China, where the name 钙尔奇 is used for products marketed around calcium and vitamin supplementation. The brand's international presence is therefore shaped by local product formulas, regulatory requirements, distribution agreements, and ownership structures rather than by a single globally identical assortment.

Caltrate developed as a branded calcium-supplement business rather than as a diversified consumer-goods company. Its core proposition is the delivery of calcium through calcium carbonate, with selected products adding vitamin D and other minerals. The brand's commonly referenced dosage level of 600 milligrams of calcium carbonate per serving helped distinguish it from the lower calcium quantities typically found in general multivitamin products. The ownership history of Caltrate has followed broader changes in the pharmaceutical and consumer-health sectors. The brand was originally owned by Pfizer, including through the company's connection with Wyeth, and it has also been associated with GlaxoSmithKline. These relationships reflect brand and portfolio arrangements that have differed over time and by market. In Japan, the brand has been associated with Hisamitsu Pharmaceutical, illustrating that local commercialization has not necessarily followed the same structure as in the United States. Caltrate has been supplied in several formulas rather than as one standardized global product. The calcium source described for the brand is calcium carbonate, while calcium citrate is not the characteristic ingredient identified in the reference material. A commonly cited Caltrate product contains 600 milligrams of calcium carbonate. Caltrate Plus is described as adding 800 international units of vitamin D, 20 micrograms of vitamin K1, 50 milligrams of magnesium, 7.5 milligrams of zinc oxide, 1 milligram of copper, and 1.8 milligrams of manganese sulfate monohydrate. These details apply to the referenced formulation and should not be assumed to describe every product sold under the brand. The brand expanded its consumer-health relevance through multiple dosage forms and market-specific assortments, including tablets and, in some markets, chewable or gummy products. Its commercial message has generally emphasized calcium intake and bone health, with vitamin D positioned as a complementary nutrient in selected formulas. Caltrate has been particularly visible in the Chinese market under the name 钙尔奇, although availability, claims, and formulas are determined by local registration and labeling rules. In the modern consumer-health landscape, Caltrate is identified as a Haleon brand. Haleon was formed as a standalone consumer-health company following the separation of consumer-health operations from their former corporate structures. Caltrate's present identity is therefore connected to Haleon's portfolio of self-care, wellness, and nutrition brands. The brand remains active, but detailed information on its founding date, headquarters, executive leadership, sales, and market-by-market ownership is not established by the supplied reference material.

• Caltrate established as a calcium-supplement brand

  [1]Caltrateen.wikipedia.org

  The brand became associated with calcium carbonate supplementation and products designed to provide substantially more calcium than a typical multivitamin.

• Ownership associated with Pfizer and Wyeth

  [1]Caltrateen.wikipedia.org

  Caltrate was originally owned by Pfizer, including through the company's former Wyeth portfolio.

• International commercialization broadened

  [1]Caltrateen.wikipedia.org

  The brand was commercialized through different corporate arrangements, including an association with GlaxoSmithKline and a Japan-specific association with Hisamitsu Pharmaceutical.

• Brand identified with Haleon

  [1]Caltrateen.wikipedia.org

  Caltrate became part of Haleon's consumer-health brand portfolio.

A mainstream-to-premium consumer health supplement brand focused on convenient calcium intake, bone-health support, and calcium formulas supplemented with vitamin D or other micronutrients.

• Calcium and vitamin D supplement

  Caltrate 600+D

  A Caltrate formulation centered on calcium carbonate and paired with vitamin D. The product name refers to a commonly cited 600-milligram calcium amount, while exact serving instructions and nutrient quantities can vary by market and package.

• Calcium and multimineral supplement

  Caltrate Plus

  A broader nutrient formula combining calcium carbonate with vitamin D3 and several minerals. The referenced formulation includes vitamin K1, magnesium, zinc, copper, and manganese in addition to its calcium component.

• Gummy dietary supplement

  Caltrate Gummy

  A gummy-format Caltrate offering intended to provide an alternative to conventional tablets. Availability and nutritional composition are market-specific and should be confirmed from current local packaging.

1. 1Caltrateen.wikipedia.org